Results

Total Results: 1,546 records

Showing results for "drug".

121. Microsoft Word - ehcrr#2toCSI.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
     August 01, 2007 - Psychotropic drug use in elderly people with and without dementia. … The quality of antipsychotic drug prescribing in nursing homes. … Food and Drug Administration. … Available at: www.fda.gov/cder/drug/advisory/antipsychotics.ht m. … Paradoxical relations of drug treatment with mortality in older persons.

122. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol

123. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update

124. Ced -Appendix-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
     May 29, 2025 - Application of CED to an on-label use of a drug or biological is contrary to the requirements of the … controlled trials (RTCs) and to incorporate real-world evidence (RWE) Exclude on-label use of Food and Drug … drugs and biologicals be excluded from CED restrictions Application of CED to an on-label use of a drug … Requirements for post-FDA-approval real-world evidence development that is based on coverage to label for any drug

125. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - (aspirin) versus VKA (2 RCTs, one NRCS), LMWH versus antiplatelet drug (2 NRCSs), antiplatelet drug … versus FXaI (1 RCT), antiplatelet drug versus mechanical devices (1 RCT, 1 NRCS), antiplatelet drug … drug and mechanical device; LMWH alone versus combinations of LMWH and antiplatelet drug, DTI, FXaI … drug, UFH, and mechanical device. … Across this study set, 12 classes were evaluated (antiplatelet drug [aspirin], antiplatelet drug plus

126. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - (aspirin) versus VKA (2 RCTs, one NRCS), LMWH versus antiplatelet drug (2 NRCSs), antiplatelet drug … versus FXaI (1 RCT), antiplatelet drug versus mechanical devices (1 RCT, 1 NRCS), antiplatelet drug … drug and mechanical device; LMWH alone versus combinations of LMWH and antiplatelet drug, DTI, FXaI … drug, UFH, and mechanical device. … Across this study set, 12 classes were evaluated (antiplatelet drug [aspirin], antiplatelet drug plus

127. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug … We simplified the PRT strategy by using designed delays (DD) to evaluate drug policies. … covering the elderly, the poor, and families with high drug expenditures, introduced a drug benefit … Periodic letters on evidence- based drug therapy improves prescribing: a randomized trial. … Randomized controlled trial of a drug policy change by British Columbia PharmaCare.

128. Reducing Adverse Drug Events Related to Anticoagulant Use in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research

129. Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stent-clopidogrel-practice/research

130. Developing Evidence-Based Research Priorities for Off-Label Drug Use | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/off-label-use-research-priorities/research

131. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - Mifepristone, a drug for psychotic major depression (PMD), a condition for which no U.S. … administration and is known to be a street drug of abuse. … Research suggests new drug targets for depression. … Food and Drug Administration (FDA) [accessed 2012 Mar 15]. [2 p]. … Washington (DC): Drug Enforcement Administration, U.S.

132. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Drug Enforcement Administration. … The drug was subsequently studied for its potential to reduce IBS symptoms, such as diarrhea. … Food and Drug Administration (FDA) for treating diarrhea-predominant IBS. … Some experts believe that concerns about overuse of antibiotics might limit the use of the drug. … Food and Drug Administration (FDA); 2015 May 27 [accessed 2015 Jun 03]. [5 p].

133. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
     September 19, 2014 - *Including opioid management plans, patient education, urine drug screening, use of prescription drug … The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related … Food and Drug Administration. … Food and Drug Administration. … Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?

134. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - Naltrexone/bupropion combination drug is an oral, sustained-release drug intended to fight the body's … Food and Drug Administration (FDA). … Pharmaceutical companies struggle to develop a drug to treat obesity. … Lorcaserin: FDA issues complete response letter for Lorcaserin new drug application. … FDA accepts new drug application filing for Qnexa. [internet].

135. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Tufts University Boston, MA Katharine Lillie, MD Center for Drug Evaluation & Research, Food & Drug … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s … (drug-drug interactions) In August 2012, FDA reported an association between Lovaza and recurrent … Clinical or intermediate harms with cardiovascular drug(s) plus supplement versus drug(s) plus placebo … Pharmacokinetic outcomes with cardiovascular drug(s) plus supplement versus drug(s) plus placebo, no

136. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

137. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

138. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. … Vertex's two-drug cystic fibrosis treatment shows promise. [internet]. … FDA panel backs Vertex cystic-fibrosis drug Orkambi. Wall Str J. 2015 May 12. … National drug list: drug list - three (3) tier drug plan. … HealthPartners PreferredRx: preferred drug list (formulary). [internet].

139. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     May 29, 2025 - So you can look and you can say, OK, what drug are they taking. They're taking Gabapentin. … amount of additional information about the utilization of that drug in the real world. … So it limits misattribution of things like nausea if someone's taking a drug and saying, OK, you know … What's the likelihood that my nausea today is being caused by this drug? … We had 10 times as many people on drug and 30 times as many controls in our trial, in observational

140. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April … Introduction Comparative Effectiveness Review (CER) #55, Drug Therapy for Rheumatoid Arthritis in … This drug is not a biologic. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … Risk did not differ significantly by specific drug.